AC Immune SA (ACIU)
2.35
+0.06
(+2.62%)
USD |
NASDAQ |
Apr 26, 16:00
2.35
0.00 (0.00%)
After-Hours: 20:00
AC Immune Price: 2.35 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 26, 2024 | 2.30 | 2.495 | 2.25 | 2.35 | 107791.0 |
Apr 25, 2024 | 2.35 | 2.40 | 2.27 | 2.29 | 160428.0 |
Apr 24, 2024 | 2.40 | 2.47 | 2.33 | 2.37 | 322914.0 |
Apr 23, 2024 | 2.45 | 2.51 | 2.37 | 2.38 | 189610.0 |
Apr 22, 2024 | 2.39 | 2.51 | 2.355 | 2.42 | 208131.0 |
Apr 19, 2024 | 2.40 | 2.49 | 2.311 | 2.36 | 316801.0 |
Apr 18, 2024 | 2.41 | 2.49 | 2.36 | 2.38 | 369340.0 |
Apr 17, 2024 | 2.45 | 2.69 | 2.42 | 2.42 | 250553.0 |
Apr 16, 2024 | 2.49 | 2.54 | 2.45 | 2.45 | 168401.0 |
Apr 15, 2024 | 2.73 | 2.799 | 2.49 | 2.52 | 113095.0 |
Apr 12, 2024 | 2.76 | 2.77 | 2.69 | 2.74 | 39028.00 |
Apr 11, 2024 | 2.79 | 3.02 | 2.71 | 2.73 | 124110.0 |
Apr 10, 2024 | 2.80 | 2.90 | 2.69 | 2.80 | 173791.0 |
Apr 09, 2024 | 2.84 | 2.875 | 2.751 | 2.80 | 229991.0 |
Apr 08, 2024 | 2.79 | 2.850 | 2.69 | 2.80 | 302303.0 |
Apr 05, 2024 | 2.74 | 2.84 | 2.72 | 2.75 | 1.124M |
Apr 04, 2024 | 2.84 | 2.860 | 2.73 | 2.75 | 30061.00 |
Apr 03, 2024 | 2.71 | 2.86 | 2.64 | 2.80 | 112507.0 |
Apr 02, 2024 | 2.74 | 2.785 | 2.56 | 2.70 | 194455.0 |
Apr 01, 2024 | 3.00 | 3.00 | 2.68 | 2.73 | 197724.0 |
Mar 28, 2024 | 3.07 | 3.18 | 2.93 | 2.96 | 168448.0 |
Mar 27, 2024 | 2.83 | 3.17 | 2.83 | 3.03 | 193211.0 |
Mar 26, 2024 | 2.95 | 3.03 | 2.65 | 2.84 | 984868.0 |
Mar 25, 2024 | 3.04 | 3.200 | 2.85 | 2.90 | 207722.0 |
Mar 22, 2024 | 3.21 | 3.21 | 2.97 | 3.07 | 260750.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.72
Minimum
Dec 22 2022
9.89
Maximum
Jan 15 2020
4.937
Average
4.94
Median
May 06 2019
Price Benchmarks
CRISPR Therapeutics AG | 53.91 |
Addex Therapeutics Ltd | 16.10 |
NLS Pharmaceutics Ltd | 0.1367 |
Molecular Partners AG | 3.88 |
MoonLake Immunotherapeutics | 42.49 |
Price Related Metrics
Price to Book Value | 1.215 |
Earnings Yield | -30.19% |
Market Cap | 232.41M |